PWUPU

Aspire Biopharma Holdings, Inc.

A biopharmaceutical company developing a sublingual (under-the-tongue) drug delivery platform that lets medications and supplements absorb quickly into the bloodstream, skipping the stomach and liver. Founded in 2021, it came to life when the earlier shell company PowerUp Acquisition Corp. merged with it in early 2025 and the combined business took the name Aspire. The name "Aspire" nods to ambition, though the company has never spelled out a story behind it—a small mystery fans of naming lore can chew on.

Units consisting of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant exercisable for one Class A ordinary share at 1.50

Recent Activity

Show $

2023Q3

1 sell

FPA Crescent FundEXIT

-46.9K shares

FPA Crescent FundEXIT

-46.9K shares

Loading more activity...